Henriette E. Meyer zu Schwabedissen graduated 2004 from the School of Medicine of the Ernst-Moritz-Arndt University of Greifswald, and obtained her M.D and license to practice in the same year. From 2004 to 2006 she was Resident at the Institute of Pharmacology at the University of Greifswald. In 2006 funded by the Deutsche Forschungsgemeinschaft she joined the Group of Richard B. Kim in the Department of Clinical Pharmacology at the Vanderbilt University, Nashville, TN, USA. In the same year she transferred with the group of Richard B. Kim to the University of Western Ontario, London, ON in Canada. At the end of the year 2008 she became Senior Scientist/Resident in the C_DAT Center of Drug Absorption and Transport (Department of Pharmacology) at the University of Greifswald, where she obtained a Habilitation in 2011. In March 2013 she was appointed Assistant Professor for Biopharmacy at the Department of Pharmaceutical Sciences at the University of Basel, and was promoted to Associate Professor in 2015 and to Full Professor in 2024.

Her scientific interests are drug transporters and their interplay with nuclear receptors. Both mechanisms play a pivotal role in pharmacology and physiology this translational aspect is major focus of her current research projects.

Other activities

• Since 2022: Member of the Research Committee of the University of Basel
• Since 2017: Member of the Scientific Advisory Board of the BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
• Since 2016: Departmental representative at the “Promotionsausschuss” of the Faculty of Natural Sciences
• 2015-2021: Chair of the Commission for equal opportunities of the Faculty of Natural Sciences
• 2015-2021: Member of the Faculty at the “Regenzkommission Chancengleichheit”
• 2015-2021: Departmental representative at the “Beförderungskommission” of the Faculty of Natural Sciences
• 2015-2021: Departmental representative at the “Regenz” of the University of Basel